vs
Arcutis Biotherapeutics, Inc.（ARQT）とBRC Group Holdings, Inc.（RILY）の財務データ比較。上の社名をクリックして会社を切り替えられます
BRC Group Holdings, Inc.の直近四半期売上が大きい（$188.3M vs $129.5M、Arcutis Biotherapeutics, Inc.の約1.5倍）。BRC Group Holdings, Inc.の純利益率が高く（47.9% vs 13.4%、差は34.5%）。Arcutis Biotherapeutics, Inc.の前年同期比売上増加率が高い（81.5% vs -21.9%）。過去8四半期でArcutis Biotherapeutics, Inc.の売上複合成長率が高い（61.6% vs -15.4%）
アーキューティス・バイオセラピューティクスは臨床段階のバイオ医薬品企業で、免疫介在性皮膚疾患向けの革新的な処方療法の開発・商業化に注力しています。乾癬、アトピー性皮膚炎、円形脱毛症などを対象とした製品ポートフォリオを持ち、主に米国市場の患者や医療従事者にサービスを提供しています。
ARQT vs RILY — 直接比較
売上が大きい
RILY
1.5倍大きい
$129.5M
売上成長率が高い
ARQT
+103.3%の差
-21.9%
純利益率が高い
RILY
純利益率が34.5%高い
13.4%
2年売上CAGRが高い
ARQT
2年複合成長率
-15.4%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $129.5M | $188.3M |
| 純利益 | $17.4M | $90.3M |
| 粗利率 | 91.0% | 79.5% |
| 営業利益率 | 14.2% | 32.3% |
| 純利益率 | 13.4% | 47.9% |
| 売上前年比 | 81.5% | -21.9% |
| 純利益前年比 | 261.2% | 1710.8% |
| EPS（希薄化後） | $0.14 | $2.78 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上ARQTRILY
| Q4 25 | $129.5M | $188.3M | ||
| Q3 25 | $99.2M | $215.3M | ||
| Q2 25 | $81.5M | $188.2M | ||
| Q1 25 | $65.8M | $197.2M | ||
| Q4 24 | $71.4M | $241.0M | ||
| Q3 24 | $44.8M | $225.5M | ||
| Q2 24 | $30.9M | $256.0M | ||
| Q1 24 | $49.6M | $263.4M |
純利益ARQTRILY
| Q4 25 | $17.4M | $90.3M | ||
| Q3 25 | $7.4M | $91.1M | ||
| Q2 25 | $-15.9M | $139.5M | ||
| Q1 25 | $-25.1M | $-10.0M | ||
| Q4 24 | $-10.8M | $-5.6M | ||
| Q3 24 | $-41.5M | $-284.4M | ||
| Q2 24 | $-52.3M | $-433.6M | ||
| Q1 24 | $-35.4M | $-49.2M |
粗利率ARQTRILY
| Q4 25 | 91.0% | 79.5% | ||
| Q3 25 | 91.2% | 83.7% | ||
| Q2 25 | 90.8% | 81.3% | ||
| Q1 25 | 86.6% | 81.4% | ||
| Q4 24 | 90.3% | 79.8% | ||
| Q3 24 | 87.7% | 82.1% | ||
| Q2 24 | 88.8% | 84.5% | ||
| Q1 24 | 93.4% | 85.3% |
営業利益率ARQTRILY
| Q4 25 | 14.2% | 32.3% | ||
| Q3 25 | 8.6% | 30.4% | ||
| Q2 25 | -17.9% | 5.7% | ||
| Q1 25 | -37.3% | -31.2% | ||
| Q4 24 | -10.7% | -69.2% | ||
| Q3 24 | -87.3% | -36.4% | ||
| Q2 24 | -162.3% | -90.8% | ||
| Q1 24 | -63.8% | -6.1% |
純利益率ARQTRILY
| Q4 25 | 13.4% | 47.9% | ||
| Q3 25 | 7.5% | 42.3% | ||
| Q2 25 | -19.5% | 74.1% | ||
| Q1 25 | -38.1% | -5.1% | ||
| Q4 24 | -15.1% | -2.3% | ||
| Q3 24 | -92.8% | -126.1% | ||
| Q2 24 | -169.6% | -169.4% | ||
| Q1 24 | -71.4% | -18.7% |
EPS（希薄化後）ARQTRILY
| Q4 25 | $0.14 | $2.78 | ||
| Q3 25 | $0.06 | $2.91 | ||
| Q2 25 | $-0.13 | $4.50 | ||
| Q1 25 | $-0.20 | $-0.39 | ||
| Q4 24 | $-0.09 | $-0.01 | ||
| Q3 24 | $-0.33 | $-9.39 | ||
| Q2 24 | $-0.42 | $-14.35 | ||
| Q1 24 | $-0.32 | $-1.71 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $42.9M | $226.6M |
| 総負債低いほど良い | $109.0M | $1.4B |
| 株主資本純資産 | $189.5M | $-171.5M |
| 総資産 | $433.0M | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | 0.58× | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資ARQTRILY
| Q4 25 | $42.9M | $226.6M | ||
| Q3 25 | $47.1M | $184.2M | ||
| Q2 25 | $72.7M | $267.4M | ||
| Q1 25 | $53.1M | $138.3M | ||
| Q4 24 | $71.3M | $146.9M | ||
| Q3 24 | $134.9M | $159.2M | ||
| Q2 24 | $84.3M | $236.9M | ||
| Q1 24 | $190.1M | $190.7M |
総負債ARQTRILY
| Q4 25 | $109.0M | $1.4B | ||
| Q3 25 | $108.5M | $1.3B | ||
| Q2 25 | $108.0M | $1.3B | ||
| Q1 25 | $107.6M | $1.4B | ||
| Q4 24 | $107.2M | $1.5B | ||
| Q3 24 | $204.6M | — | ||
| Q2 24 | $203.8M | — | ||
| Q1 24 | $202.8M | — |
株主資本ARQTRILY
| Q4 25 | $189.5M | $-171.5M | ||
| Q3 25 | $158.1M | $-260.5M | ||
| Q2 25 | $139.0M | $-351.7M | ||
| Q1 25 | $142.7M | $-496.8M | ||
| Q4 24 | $157.5M | $-488.2M | ||
| Q3 24 | $156.6M | $-497.6M | ||
| Q2 24 | $186.4M | $-218.3M | ||
| Q1 24 | $224.9M | $228.4M |
総資産ARQTRILY
| Q4 25 | $433.0M | $1.7B | ||
| Q3 25 | $371.0M | $1.7B | ||
| Q2 25 | $352.4M | $1.5B | ||
| Q1 25 | $344.1M | $1.5B | ||
| Q4 24 | $348.9M | $1.8B | ||
| Q3 24 | $437.4M | $2.2B | ||
| Q2 24 | $444.8M | $3.2B | ||
| Q1 24 | $478.5M | $5.0B |
負債/資本比率ARQTRILY
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 0.90× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $26.2M | $26.2M |
| フリーキャッシュフロー営業CF - 設備投資 | — | — |
| FCFマージンFCF / 売上 | — | — |
| 設備投資強度設備投資 / 売上 | 0.0% | — |
| キャッシュ転換率営業CF / 純利益 | 1.51× | 0.29× |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローARQTRILY
| Q4 25 | $26.2M | $26.2M | ||
| Q3 25 | $-1.8M | $-60.6M | ||
| Q2 25 | $324.0K | $-25.6M | ||
| Q1 25 | $-30.4M | $184.0K | ||
| Q4 24 | $-748.0K | $-2.7M | ||
| Q3 24 | $-34.7M | $19.5M | ||
| Q2 24 | $-45.1M | $111.5M | ||
| Q1 24 | $-31.6M | $135.4M |
フリーキャッシュフローARQTRILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $246.0K | — | ||
| Q1 25 | $-31.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-34.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
FCFマージンARQTRILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | -47.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -77.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
設備投資強度ARQTRILY
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
キャッシュ転換率ARQTRILY
| Q4 25 | 1.51× | 0.29× | ||
| Q3 25 | -0.24× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ARQT
セグメントデータなし
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
